SGLT2 Inhibitor–Associated Ketoacidosis vs Type 1 Diabetes–Associated Ketoacidosis
Mahesh M. Umapathysivam, Bethany Morgan, Joshua M. Inglis, Emily J. Meyer, Danny Liew, Venkatesan Thiruvenkatarajan, David Jesudason
Abstract
This cohort study examines the natural history and response to treatment of sodium glucose cotransporter 2 (SGLT2) inhibitor–associated ketoacidosis compared with that of type 1 diabetes–associated ketoacidosis.
Topics & Concepts
KetoacidosisDiabetic ketoacidosisMedicineType 2 diabetesDiabetes mellitusEndocrinologyInternal medicineCohortType 1 diabetesDiabetes Treatment and ManagementPancreatic function and diabetesDiet and metabolism studies